NASDAQ:TNXP - Tonix Pharmaceuticals Stock Price, Forecast & News

Tonix Pharmaceuticals trades on the NASDAQ under the ticker symbol "TNXP."

Tonix Pharmaceuticals's stock reverse split before market open on Wednesday, November 28th 2018. The 1-10 reverse split was announced on Tuesday, November 27th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, November 27th 2018. An investor that had 100 shares of Tonix Pharmaceuticals stock prior to the reverse split would have 10 shares after the split.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) released its earnings results on Friday, November, 8th. The company reported ($5.69) EPS for the quarter, missing the Zacks' consensus estimate of ($4.35) by $1.34. View Tonix Pharmaceuticals' Earnings History.

Tonix Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Monday, March 16th 2020. View Earnings Estimates for Tonix Pharmaceuticals.

1 brokers have issued 1-year target prices for Tonix Pharmaceuticals' stock. Their forecasts range from $1.30 to $1.30. On average, they expect Tonix Pharmaceuticals' stock price to reach $1.30 in the next year. This suggests that the stock has a possible downside of 5.8%. View Analyst Price Targets for Tonix Pharmaceuticals.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tonix Pharmaceuticals in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tonix Pharmaceuticals.

News coverage about TNXP stock has trended negative this week, according to InfoTrie Sentiment. The research group scores the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Tonix Pharmaceuticals earned a daily sentiment score of -2.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Tonix Pharmaceuticals.

Tonix Pharmaceuticals saw a decline in short interest during the month of December. As of December 31st, there was short interest totalling 103,200 shares, a decline of 66.6% from the December 15th total of 309,300 shares. Based on an average daily trading volume, of 1,490,000 shares, the days-to-cover ratio is presently 0.1 days. Currently, 1.2% of the shares of the company are short sold. View Tonix Pharmaceuticals' Current Options Chain.

Some companies that are related to Tonix Pharmaceuticals include Citius Pharmaceuticals (CTXR), Pulmatrix (PULM), Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (ZOM), Unum Therapeutics (UMRX), Vistagen Therapeutics (VTGN), Generex Biotechnology (GNBT), Aptevo Therapeutics (APVO), Akari Therapeutics (AKTX), Spring Bank Pharmaceuticals (SBPH), Addex Therapeutics (ADDXF), AzurRx BioPharma (AZRX), Fibrocell Science (FCSC), VIVUS (VVUS), Bellerophon Therapeutics (BLPH) and Dare Bioscience (DARE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Tonix Pharmaceuticals investors own include Rite Aid (RAD), SCYNEXIS (SCYX), Inovio Pharmaceuticals (INO), Novavax (NVAX), Actinium Pharmaceuticals (ATNM), Sorrento Therapeutics (SRNE), Synthetic Biologics (SYN), Opko Health (OPK), AVEO Pharmaceuticals (AVEO) and Anavex Life Sciences (AVXL).

Shares of TNXP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of TNXP stock can currently be purchased for approximately $1.38.

Tonix Pharmaceuticals has a market capitalization of $8.57 million. The company earns $-26,090,000.00 in net income (profit) each year or ($268.10) on an earnings per share basis. Tonix Pharmaceuticals employs 12 workers across the globe.View Additional Information About Tonix Pharmaceuticals.

The official website for Tonix Pharmaceuticals is http://www.tonixpharma.com/.

Tonix Pharmaceuticals' mailing address is 509 MADISON AVENUE SUITE 1608, NEW YORK NY, 10022. The company can be reached via phone at 212-980-9155 or via email at [email protected]